Purdue Pharma Files New Bankruptcy Plan for $7.4 Billion Opioid Settlement

The oxycodone manufacturer was sued by states, local governments, and individuals for its alleged role in creating the opioid crisis.

Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo, Utah, on April 25, 2017. George Frey/Reuters

Drugmaker Purdue Pharma filed a new bankruptcy plan on March 18, a major step toward finalizing a proposed opioid settlement of $7.4 billion.

The maker of the powerful semi-synthetic opioid oxycodone—also marketed as OxyContin and by other names—filed a Chapter 11 reorganization plan and related disclosure statement with the U.S. Bankruptcy Court for the Southern District of New York.